Details for New Drug Application (NDA): 019530
✉ Email this page to a colleague
The generic ingredient in UCEPHAN is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.
Summary for 019530
Tradename: | UCEPHAN |
Applicant: | B Braun |
Ingredient: | sodium benzoate; sodium phenylacetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 100MG/ML;100MG/ML | ||||
Approval Date: | Dec 23, 1987 | TE: | RLD: | No |
Expired US Patents for NDA 019530
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
B Braun | UCEPHAN | sodium benzoate; sodium phenylacetate | SOLUTION;ORAL | 019530-001 | Dec 23, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription